Founders whose skills were yet to be proven across cycles, drinking the “growth at any price” kool aid because of easy availability of capital and getting into ill advised financial structuring (pledging shares, borrowing money for expansion not yet supported by good unit economics)…
Now getting their own equity diluted away to next to nothing after the tech funding tap dried up for just a year
Hope a business like Thyrocare (that always had a future) doesn’t pay the price for the low quality risk management thinking of the new owners
| Subscribe To Our Free Newsletter |
